Radiotherapy to the neck after neck dissection for head and neck squamous cell carcinoma from an unknown primary: A narrative review
- 28 March 2024
- journal article
- review article
- Published by Wiley in Clinical Otolaryngology
- Vol. 49 (4) , 376-383
Abstract
Purpose: To conduct a comprehensive narrative review of the evidence for radiotherapy target volumes to the neck, after neck dissection, for head and neck squamous cell carcinoma from an unknown primary (HNSCCUP). Inclusion or exclusion of mucosal irradiation is not the focus of interest for this review article. Materials and Methods: Literature (PubMed‐Medline, EMBASE database and Cochrane library) was searched using the relevant keywords. The search results were limited to the studies published in year 2000 or after. Results: Eight studies met the inclusion criteria. All studies were retrospective in nature. The incidence of contralateral recurrence rates in the untreated neck when the involved neck only is treated remains very low (0%–10%). Survival has improved over the past two decades, most likely due to improved diagnostic techniques and the increase in incidence of HPV‐related disease. Conclusion: Given the rarity of disease, level one evidence from randomised controlled trials is lacking. Available data are retrospective but support unilateral post‐operative radiotherapy as a treatment option in selected cases.Keywords
This publication has 30 references indexed in Scilit:
- Management of unilateral head and neck carcinoma of unknown primary: Retrospective analysis of the impact of postoperative radiotherapy target volumesHead & Neck, 2019
- Unilateral radiotherapy treatment for p16/human papillomavirus–positive squamous cell carcinoma of unknown primary in the head and neckThe Laryngoscope, 2018
- Oropharynx‐directed ipsilateral irradiation for p16‐positive squamous cell carcinoma involving the cervical lymph nodes of unknown primary originHead & Neck, 2017
- A matched comparison of human papillomavirus–induced squamous cancer of unknown primary with early oropharynx cancerThe Laryngoscope, 2017
- Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data BaseCancer, 2016
- p16 status, pathologic and clinical characteristics, biomolecular signature, and long‐term outcomes in head and neck squamous cell carcinomas of unknown primaryHead & Neck, 2013
- Head and neck squamous cell carcinoma of unknown primary: Neck dissection and radiotherapy or definitive radiotherapyHead & Neck, 2013
- Tonsillar cancer: The Peter MacCallum experience with unilateral and bilateral irradiationHead & Neck, 2013
- p16 Expression in carcinoma of unknown primary: Diagnostic indicator and prognostic markerHead & Neck, 2013
- Radiotherapeutic Management of Cervical Lymph Node Metastases From an Unknown Primary SiteJAMA Otolaryngology–Head & Neck Surgery, 2012